Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

SJ, Hadziyannis; H Jr, Sette; TR, Morgan; V, Balan; M, Diago; P, Marcellin; G, Ramadori; H Jr, Bodenheimer; D, Bernstein; M, Rizzetto; S, Zeuzem; PJ, Pockros; A, Lin; AM, Ackrill

doi:10.7326/0003-4819-140-5-200403020-00010

Public

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

Shared by NobleBlocks on Mar 1, 2004 • 12:00 AM UTC

Authors:

Hadziyannis SJ

Sette H Jr

Morgan TR

Abstract

Background Treatment with pegylated interferon (peginterferon) and ribavirin for 48 weeks is more effective than conventional interferon and ribavirin in patients with chronic hepatitis C.Objective To assess the efficacy and safety of 24 or 48 weeks of treatment with peginterferon-alpha2a plus a low...

Discussions